Skip to main content
padlock icon - secure page this page is secure

Biological Properties of Citrus Flavonoids Pertaining to Cancer and Inflammation

Buy Article:

$68.00 + tax (Refund Policy)

Citrus flavonoids encompass a diverse set of structures, including numerous flavanone and flavone O- and C-glycosides and methoxylated flavones. Each of these groups of compounds exhibits a number of in vitro and in vivo anti-inflammatory and anticancer actions. These biological properties are consistent with their effects on the microvascular endothelial tissue. Evidence suggests that the biological actions of the citrus flavonoids are possibly linked to their interactions with key regulatory enzymes involved in cell activation and receptor binding. The citrus flavonoids show little effect on normal, healthy cells, and thus typically exhibit remarkably low toxicity in animals. The citrus flavonoids extend their influence in vivo through their induction of hepatic phase I and II enzymes, and through the biological actions of their metabolites. Evidence clearly indicates to the potential health promoting properties of these dietary compounds.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: ATP Binding Sites; Anti cancer properties; Arachidonic Acid Metabolism; Cancer cell proliferation; Cell Adhesion; Citrus Flavonoids; Citrus Reticulata; Hepatic Enzyme induction; Hesperdine and Diosmin; Mechanistic Studies; Microvascular Hyperpermeability; Multidrug Resistance; Non stimulated lymphocytes; Polymethoxyflavones; Vitamin P

Document Type: Review Article

Publication date: February 1, 2001

More about this publication?
  • Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more